drugset
drugset / Trial / NCT05257044

Acute Effects of Cannabigerol

NCT05257044 ↗

Phase 1 Completed 38 enrolled Washington State University
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to examine the effects of hemp-derived cannabigerol (CBG) on anxiety, stress, mood, and cognition. Further, the severity of various side effects of CBG (sleepiness, dry mouth, dry eyes, increased appetite) will be assessed. As such, the study is focused on better understanding some of the potentially beneficial and detrimental effects of CBG on humans.

Timeline

Start
2022-03-24
Primary completion
2023-11-28
Completion
2023-11-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabigerol Small molecule 20 mg —

Indications

No indication recorded.